Literature DB >> 15086557

Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis.

Toon F C M Smetsers1, Els M A van de Westerlo, Gerdy B ten Dam, Ingrid M Overes, Joost Schalkwijk, Goos N P van Muijen, Toin H van Kuppevelt.   

Abstract

Chondroitin sulfate (CS) belongs to the group of glycosaminoglycans (GAGs), which are linear polysaccharides, located in the extracellular matrix and on the cell surface. To study the structure and distribution of CS in human skin and skin disorders, we have selected antibodies using phage display technique against CS. Four unique human anti-CS single-chain antibodies were selected: IO3D9, IO3H10, IO3H12, and IO4C2. We determined their amino acid sequence and evaluated their CS reactivity using ELISA and immunohistochemistry. Antibodies were reactive with CS, but not with other GAGs except for IO4C2, which was also reactive with heparin. Antibody IO3D9 showed a strong reactivity with highly sulfated CS (CSE). All antibodies displayed a different staining pattern in rat kidney, indicating the recognition of unique CS epitopes. In normal skin, the papillary dermis but not the reticular dermis was strongly stained. Antibody IO3H12 also stained basal keratinocytes. We applied these antibodies to study CS expression and localization in melanoma and psoriasis. A strong immunoreactivity with the extracellular matrix of melanoma metastases could be observed for all four antibodies, while in atypical nevi a less extensive reactivity with only the papillary dermis was observed. In psoriatic lesions, CS could be observed in the papillary dermis and in the reticular dermis, whereas the specific location in the papillary dermis found in normal skin was completely lost. In conclusion, human phage-display-derived anti-CS antibodies have been selected, characterized, and applied to detect CS alterations in skin conditions. Altered CS composition was detected in melanoma and psoriasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086557     DOI: 10.1111/j.0022-202X.2004.22316.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  22 in total

Review 1.  Peptide-displaying phage technology in glycobiology.

Authors:  Michiko N Fukuda
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

2.  Purification and sequence characterization of chondroitin sulfate and dermatan sulfate from fishes.

Authors:  Na Lin; Xiaoli Mo; Yang Yang; Hong Zhang
Journal:  Glycoconj J       Date:  2017-01-14       Impact factor: 2.916

3.  Characterization of the interaction between the chlamydial adhesin OmcB and the human host cell.

Authors:  Tim Fechtner; Sonja Stallmann; Katja Moelleken; Klaus L Meyer; Johannes H Hegemann
Journal:  J Bacteriol       Date:  2013-09-20       Impact factor: 3.490

4.  Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.

Authors:  Markus A Loeven; Angelique L Rops; Markus J Lehtinen; Toin H van Kuppevelt; Mohamed R Daha; Richard J Smith; Marinka Bakker; Jo H Berden; Ton J Rabelink; T Sakari Jokiranta; Johan van der Vlag
Journal:  J Biol Chem       Date:  2016-01-04       Impact factor: 5.157

5.  Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfation.

Authors:  Minh Bao Huynh; Christophe Morin; Gilles Carpentier; Stephanie Garcia-Filipe; Sofia Talhas-Perret; Véronique Barbier-Chassefière; Toin H van Kuppevelt; Isabelle Martelly; Patricia Albanese; Dulce Papy-Garcia
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

6.  Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

Authors:  Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; Leon F Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

7.  Plasmodium falciparum ookinetes require mosquito midgut chondroitin sulfate proteoglycans for cell invasion.

Authors:  Rhoel R Dinglasan; Aditi Alaganan; Anil K Ghosh; Akio Saito; Toin H van Kuppevelt; Marcelo Jacobs-Lorena
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

8.  Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases.

Authors:  Audrey Deligny; Agnès Denys; Adeline Marcant; Aurélie Melchior; Joël Mazurier; Toin H van Kuppevelt; Fabrice Allain
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

9.  Histopathologies, immunolocalization, and a glycan binding screen provide insights into Plasmodium falciparum interactions with the human placenta.

Authors:  Bethann S Hromatka; Sadiki Ngeleza; Jennifer J Adibi; Richard K Niles; Antoinette K Tshefu; Susan J Fisher
Journal:  Biol Reprod       Date:  2013-06-20       Impact factor: 4.285

10.  The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.

Authors:  Bodil Fadnes; Oystein Rekdal; Lars Uhlin-Hansen
Journal:  BMC Cancer       Date:  2009-06-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.